InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 211274

Saturday, 12/10/2016 8:06:58 PM

Saturday, December 10, 2016 8:06:58 PM

Post# of 345704

Formation of amyloid fibers triggered by phosphatidylserine-containing membranes.



On the week that "amyloid fibers" is hitting the news and how relevant it is to Alzheimers..... one should ask the more important question.

How can we effectively treat the build of amyloid fibers ??

Then maybe one should go back and read the post this was in reply to and find out.

PS Targeting.

PS Targeting.

PS Targeting.

I've seen some stocks work 4 Billion market cap for just A SINGLE cancer indication .... so what is the value of a PS Targeting pipeline?

Big Pharma is afraid of that answer


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News